Flexible Anti-thrombotic LVADs
灵活的抗血栓 LVAD
基本信息
- 批准号:10575664
- 负责人:
- 金额:$ 23.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-19 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAdsorptionAffinityAnalysis of VarianceArchitectureAtomic Force MicroscopyBloodBlood CellsBlood ProteinsChemicalsComplexCoupledCustomDevelopmentDiffuseElectrostaticsEvaluationFeasibility StudiesFuture GenerationsGenerationsGoalsGrantHardnessHeartHeart TransplantationHeart failureHemolysisHemorrhageHydration statusImageIn VitroInstitutesJointsLateralLeadMeasurementMeasuresMethodsMolecularNormalcyNorth CarolinaOpticsPatient-Focused OutcomesPatientsPerformancePolymersPolyurethanesProblem SolvingPropertyProteinsPublic HealthPumpQuality of lifeReactionRecording of previous eventsResearchResolutionRiskRoentgen RaysSpectrum AnalysisStatistical Data InterpretationStructureSurfaceTechnologyTestingTherapeuticThrombosisTimeUniversitiesVelocimetriesWaterWingWorkabsorptionblood damagecare burdendesigneffective therapyflexibilityhemocompatibilityhemodynamicshydrophilicityimplantable deviceinnovationleft ventricular assist devicenovelparticlepatient mobilityresponsesuccess
项目摘要
PROJECT SUMMARY
Left ventricular assist device (LVAD) is a promising therapeutic option for end-stage heart failure patients,
besides cardiac transplant, which is limited by the number of available donors. However, severe complications,
including bleeding and thrombosis, significantly worsen the long-term outcome of the patients. This proposed
joint effort aims to solve these problems by reducing blood damage using flexible rotors and dramatically
reducing pump thrombosis through novel Slippery Hydrophilic (SLIC) coatings. The objective of this project is
to develop a novel LVAD with flexible polymeric rotors and novel anti-thrombotic coatings that can dramatically
reduce blood damage and dramatically reduce the risk of pump thrombosis.
Development of the flexible anti-thrombotic LVAD requires careful optimization of the flexible rotors and SLIC
coatings. In Aim 1, Characterization and Optimization of Flexible Polymeric Rotors to Reduce Blood Damage,
we will design, fabricate and test rotors with a wide range of flexibilities. Flexible, water-clear polyurethanes will
be used for the rotor, which grants optical access to the rotor passage. Durability will be characterized in this
aim through a custom-built accelerated hydrodynamic testing rig. The hemodynamic performance and blood
damage potential of the flexible LVAD with SLIC coatings will be characterized in-vitro using 2D and 3D particle
image velocimetry.
Blood damage caused to the blood cells will be quantified experimentally by evaluating the
shear history obtained from 3D time-resolved particle tracking. In Aim 2, Optimize SLIC coatings for Maximum
Anti-thrombotic Response, we propose to fabricate SLIC coatings on polymeric surfaces and characterize the
physical and chemical inhomogeneities through Atomic Force Microscopy (AFM),contact angle goniometry
(advancing and receding angle measurements). X-ray photoelectron spectroscopy (XPS), near-edge x-ray
absorption fine structure (NEXAFS), electrostatic force microscopy (EFM), to maximize the anti-thrombotic
response. The optimized LVAD with flexible rotors and SLIC coatings will be thoroughly evaluated in-vitro using
a blood loop under both quasi-steady and dynamic conditions. Levels of the blood damage and thrombosis
potential will be compared with a rigid counterpart with and without SLIC coatings, along with statistical analysis.
We hypothesize that through optimized polymeric flexible blade designs and SLIC coatings, LVADs can achieve
excellent hemocompatibility, dramatically reducing blood damage and thrombosis. This novel design coupled
with the unique SLIC coating has the potential to be used in future generations of LVADs that can provide
long-term support to end-stage heart failure patients as a non-inferior alternative to cardiac transplants.
项目摘要
左心室辅助装置(LVAD)是终末期心力衰竭患者的一种有前途的治疗选择,
除了心脏移植,这是有限的数量可用的捐赠者。然而,严重的并发症,
包括出血和血栓形成,显著恶化了患者的长期结果。这一拟议
联合努力旨在通过使用柔性转子减少血液损伤来解决这些问题,
通过新型的Slippery Hydrophilic(SLIC)涂层减少泵血栓形成。本项目的目标是
开发一种具有柔性聚合物转子和新型抗血栓涂层的新型LVAD,
减少血液损伤并显著降低泵血栓形成的风险。
开发柔性抗血栓LVAD需要仔细优化柔性转子和SLIC
镀层.在目标1中,柔性聚合物转子的表征和优化以减少血液损伤,
我们将设计,制造和测试具有广泛灵活性的转子。柔性、水透明聚氨酯将
用于转子,这赠款光学访问转子通道。耐久性的特点是
aim通过定制的加速流体动力学试验台。血流动力学性能和血液
将使用2D和3D粒子在体外表征具有SLIC涂层的柔性LVAD的损伤潜力
图像测速
对血细胞造成的血液损伤将通过评估血液中的
从3D时间分辨颗粒跟踪获得的剪切历史。在目标2中,优化SLIC涂层,
抗血栓反应,我们建议在聚合物表面上制备SLIC涂层,并表征
通过原子力显微镜(AFM)、接触角测角法测量物理和化学不均匀性
(前进和后退角度测量)。X射线光电子能谱(XPS),近边X射线
吸收精细结构(NEXAFS),静电力显微镜(EFM),以最大限度地提高抗血栓形成
反应将使用以下方法在体外对具有柔性转子和SLIC涂层的优化LVAD进行彻底评估:
在准稳态和动态条件下的血液回路。血液损伤和血栓形成水平
将与有和无SLIC涂层的刚性对应物进行比较,沿着统计分析。
我们假设,通过优化的聚合物柔性刀片设计和SLIC涂层,LVAD可以实现
优异的血液相容性,显著降低血液损伤和血栓形成。这种新颖的设计
具有独特的SLIC涂层,有可能用于未来几代LVAD,
长期支持终末期心力衰竭患者作为心脏移植的非劣效替代方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lakshmi Prasad Dasi其他文献
BIOMECHANICAL FLOW MODELING USING PATIENT-SPECIFIC 3D PRINTED MODEDLS FOR SURGICAL DECISION-MAKING IN ANOMALOUS AORTIC ORIGIN OF CORONARY ARTERY
- DOI:
10.1016/s0735-1097(21)01808-8 - 发表时间:
2021-05-11 - 期刊:
- 影响因子:
- 作者:
Yasaman Farsiani;Jayanthi Parthasarathy;Silvana Molossi;Carlos Mery;Atefeh Razavi;Lakshmi Prasad Dasi;Rajesh Krishnamurthy - 通讯作者:
Rajesh Krishnamurthy
COMPUTATIONAL MODELING OF CORONARY OBSTRUCTION IN VALVE-IN-VALVE TAVR: CHOOSING THE RIGHT VIRTUAL VALVE TO CORONARY DISTANCE
- DOI:
10.1016/s0735-1097(22)01769-7 - 发表时间:
2022-03-08 - 期刊:
- 影响因子:
- 作者:
Sri Krishna Sivakumar;Pradeep Yadav;Venkateshwar R. Polsani;Vinod H. Thourani;Lakshmi Prasad Dasi - 通讯作者:
Lakshmi Prasad Dasi
SINUS AND NEO-SINUS FLOW EVALUATION AFTER IMPLANTATION OF AN EVOLUT, SAPIEN 3, ACCURATE NEO AND ALLEGRA TRANSCATHETER VALVES
- DOI:
10.1016/s0735-1097(21)03064-3 - 发表时间:
2021-05-11 - 期刊:
- 影响因子:
- 作者:
Hoda Hatoum;Shelley Gooden;Janarthanan Sathananthan;Scott Lilly;Abdul Rahman Ihdayhid;Vinod Thourani;Lakshmi Prasad Dasi - 通讯作者:
Lakshmi Prasad Dasi
Lifetime Management for Aortic Stenosis: Strategy and Decision-Making in the Current Era
主动脉瓣狭窄的终身管理:当代的策略与决策
- DOI:
10.1016/j.athoracsur.2024.05.047 - 发表时间:
2025-02-01 - 期刊:
- 影响因子:3.900
- 作者:
Shmuel Chen;Andrei Pop;Lakshmi Prasad Dasi;Isaac George - 通讯作者:
Isaac George
REAL-TIME COMPUTATIONAL MODELING FOR DEPLOYMENT OF TRANSCATHETER AORTIC VALVE PROSTHESES VIA REDUCED ORDER MODELS
- DOI:
10.1016/s0735-1097(24)02987-5 - 发表时间:
2024-04-02 - 期刊:
- 影响因子:
- 作者:
Imran Shah;Sri Krishna Sivakumar;Francesco Ballarin;Venkateshwar R. Polsani;Vinod H. Thourani;Alessandro Veneziani;Lakshmi Prasad Dasi - 通讯作者:
Lakshmi Prasad Dasi
Lakshmi Prasad Dasi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lakshmi Prasad Dasi', 18)}}的其他基金
Maglev LVAD with expandable stented inlet and anti-thrombotic coating to improve hemocompatibility
磁悬浮 LVAD 具有可扩张支架入口和抗血栓涂层,可改善血液相容性
- 批准号:
10736998 - 财政年份:2023
- 资助金额:
$ 23.94万 - 项目类别:
CBT@EmTech - CardioVascular Biomechanics Training Program at Emory and GaTech
CBT@EmTech - 埃默里大学和 GaTech 的心血管生物力学培训计划
- 批准号:
10714694 - 财政年份:2023
- 资助金额:
$ 23.94万 - 项目类别:
Superomniphobic flow controlled prosthetic heart valve
超全疏流控制人工心脏瓣膜
- 批准号:
10127145 - 财政年份:2017
- 资助金额:
$ 23.94万 - 项目类别:
Hyaluronan enhanced polymeric heart valve prosthesis
透明质酸增强型聚合物人工心脏瓣膜
- 批准号:
9251521 - 财政年份:2016
- 资助金额:
$ 23.94万 - 项目类别:
Cost Effective Trileaflet BioPolymeric Heart Valve For India
印度具有成本效益的三叶生物聚合心脏瓣膜
- 批准号:
9147571 - 财政年份:2015
- 资助金额:
$ 23.94万 - 项目类别:
Cost Effective Trileaflet BioPolymeric Heart Valve For India
印度具有成本效益的三叶生物聚合心脏瓣膜
- 批准号:
8607819 - 财政年份:2015
- 资助金额:
$ 23.94万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 23.94万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 23.94万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 23.94万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 23.94万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 23.94万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 23.94万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 23.94万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 23.94万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 23.94万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 23.94万 - 项目类别:
Research Grant














{{item.name}}会员




